SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-16-011016
Filing Date
2016-08-12
Accepted
2016-08-12 07:14:01
Documents
11
Period of Report
2016-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5153
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 421034
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 299352
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 6827
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6815
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 9307
7 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 6721
8 GRAPHIC exhibit99-2x6x1.jpg GRAPHIC 20802
9 GRAPHIC exhibit99-2x7x1.jpg GRAPHIC 21674
10 GRAPHIC exhibit99-2x8x1.jpg GRAPHIC 9912
11 GRAPHIC exhibit99-5x1x1.jpg GRAPHIC 4864
  Complete submission text file 0001062993-16-011016.txt   838319
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 161826205
SIC: 2834 Pharmaceutical Preparations